FiercePharmaPolitics—Gilead CEO sees COVID-19 changing the drug pricing conversation

4th May 2020 Uncategorised 0

With less than six months to go until the U.S. elections, the drugmakers find themselves in a different position than expected at the start of the year. Because of the COVID-19 pandemic, the public will recognize pharma’s ability to innovate and help, Gilead CEO Daniel O’Day said.

More: FiercePharmaPolitics—Gilead CEO sees COVID-19 changing the drug pricing conversation
Source: fierce